Back to Industry News
General
Zinzino Acquires Bodē Pro for North America and Japan Expansion
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Dagens industri
Photo by Shigeki Wakabayashi on Unsplash
Stay updated on stories like this
Key takeaways
- **Zinzino AB Acquires Bodē Pro to Accelerate Global Growth and Market Expansion** Zinzino AB has announced a strategic acquisition of U
- -based direct sales company Bodē Pro, marking a significant advancement in its global growth strategy
- This move aligns with Zinzino's focus on personal health and well-being, leveraging biotechnology and a direct sales model
**Zinzino AB Acquires Bodē Pro to Accelerate Global Growth and Market Expansion**
Zinzino AB has announced a strategic acquisition of U.S.-based direct sales company Bodē Pro, marking a significant advancement in its global growth strategy. This move aligns with Zinzino's focus on personal health and well-being, leveraging biotechnology and a direct sales model. The acquisition encompasses Bodē Pro's distributor database, customer register, inventory, and intellectual property rights.
Bodē Pro operates within the health and wellness sector, with a strong presence in North America and Japan. The company generates an annual turnover of approximately $7 million USD. Zinzino anticipates substantial growth from this acquisition through network synergies and the integration of its proprietary test-based product concept with Bodē Pro's innovative offerings. Zinzino plans to utilize its existing technological infrastructure and organizational framework to optimize the profitability of the acquired business.
A key strategic advantage of this acquisition is the accelerated expansion into Japan, a highly desirable market within the direct sales industry. Bodē Pro currently derives approximately 55% of its total revenue from Japan.
The financial terms of the acquisition include a fixed payment of $2 million USD at closing, to be settled equally with newly issued Zinzino shares and cash. Furthermore, a deferred payment of $0.4 million USD is stipulated, along with potential earn-out payments of up to $3.6 million USD. These earn-out payments will be made exclusively in Zinzino shares, contingent upon future sales performance.
Related Topics
ZinzinoBodē ProAcquisitionDirect SalesHealth and WellnessNorth AmericaJapanExpansion
Never miss stories like this